Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Cost of RevenueEBIATLong-Term Debt IssuancesShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Greater Cannabis Company (GCAN) Cost of Revenue (2017 - 2026)

Greater Cannabis Company has reported Cost of Revenue over the past 6 years, most recently at $11017.0 for Q4 2022.

  • For Q4 2022, Cost of Revenue changed N/A year-over-year to $11017.0; the TTM value through Dec 2022 reached $52035.0, down 47.05%, while the annual FY2025 figure was $60788.0, 94.36% up from the prior year.
  • Cost of Revenue for Q4 2022 was $11017.0 at Greater Cannabis Company, down from $18054.0 in the prior quarter.
  • Over five years, Cost of Revenue peaked at $107077.0 in Q2 2019 and troughed at -$162088.0 in Q4 2019.
  • A 5-year average of $14968.1 and a median of $18364.5 in 2020 define the central range for Cost of Revenue.
  • On a YoY basis, Cost of Revenue climbed as much as 71763.76% in 2019 and fell as far as 903.69% in 2019.
  • Year by year, Cost of Revenue stood at $20168.0 in 2018, then plummeted by 903.69% to -$162088.0 in 2019, then soared by 111.52% to $18675.0 in 2020, then soared by 189.63% to $54088.0 in 2021, then crashed by 79.63% to $11017.0 in 2022.
  • Business Quant data shows Cost of Revenue for GCAN at $11017.0 in Q4 2022, $18054.0 in Q3 2022, and $11784.0 in Q2 2022.